How to Get Crestor (Rosuvastatin) in California

At a glance
- Drug / rosuvastatin (brand: Crestor), oral tablet, taken once daily
- Prescription required / yes, Schedule: non-controlled
- California telehealth prescribing / fully permitted under CA Business and Professions Code §2290.5
- Who can prescribe / MDs, DOs, NPs (independent practice), PAs (with supervising physician)
- Generic price range / $4 to $15 per month (30-day supply, 10 mg to 20 mg)
- Brand Crestor price / approximately $300 to $370 per month without insurance
- Medi-Cal (Medicaid) status / covered with prior authorization
- Compounding / available via licensed 503A pharmacies in California
- Labs required before starting / fasting lipid panel, liver function tests (ALT/AST), fasting glucose or HbA1c
- Time from visit to medication / same-day to 3 business days for most retail pharmacies
Why Rosuvastatin Is One of the Most Prescribed Statins in California
Rosuvastatin is the most potent statin available per milligram, capable of reducing LDL cholesterol by 45% to 55% at the standard 10 mg to 20 mg dose range [1]. The JUPITER trial (N=17,802) demonstrated that rosuvastatin 20 mg reduced major cardiovascular events by 44% compared to placebo in patients with elevated high-sensitivity C-reactive protein but normal LDL levels [1]. That trial shifted clinical thinking about who benefits from statin therapy.
Rosuvastatin vs. Other Statins
Among the seven marketed statins, rosuvastatin and atorvastatin dominate prescribing volume in California. Rosuvastatin has a longer half-life (approximately 19 hours) and reaches peak LDL reduction at a lower absolute dose than atorvastatin. The 2018 AHA/ACC Cholesterol Guideline classifies rosuvastatin 20 mg to 40 mg as "high-intensity" statin therapy, recommending it for adults with clinical atherosclerotic cardiovascular disease (ASCVD) or LDL ≥190 mg/dL [2].
California Prescribing Volume
California is the largest pharmaceutical market in the United States. Rosuvastatin ranked among the top 10 most-dispensed generic drugs in the state in 2024, according to California Board of Pharmacy dispensing data. The generic became available in 2016 after AstraZeneca's patent expiration, and prices dropped by more than 90% within three years.
Who Can Prescribe Rosuvastatin in California
Any California-licensed prescriber with an active DEA registration (or equivalent authority) can write a rosuvastatin prescription. The drug is non-controlled, so prescribing rules are straightforward.
Physicians (MD/DO)
All licensed California physicians can prescribe rosuvastatin. No special certification or consultation is needed. Primary care physicians, internists, cardiologists, and endocrinologists are the most common prescribers.
Nurse Practitioners (NPs)
California Assembly Bill 890, effective January 1, 2023, granted NPs independent practice authority after meeting specific transition-to-practice requirements (a minimum of 4,600 hours of supervised clinical experience). NPs who have completed this transition can prescribe rosuvastatin without physician supervision. NPs still in the transition period may prescribe under a standardized procedure with a supervising physician [3].
Physician Assistants (PAs)
California PAs prescribe under a practice agreement with a supervising physician, per Business and Professions Code §3502.1. For a non-controlled medication like rosuvastatin, PA prescribing is routine and does not require the physician to co-sign the prescription.
How Telehealth Works for Crestor Prescriptions in California
California is one of the most telehealth-friendly states in the country. A virtual visit is often the fastest route to a rosuvastatin prescription.
Legal Framework
California Business and Professions Code §2290.5 authorizes telehealth for any clinical service where the standard of care can be met remotely. Prescribing a statin after reviewing labs and medical history fits comfortably within this standard. No in-person visit is required before or after the telehealth encounter for non-controlled substances [4].
What Happens During a Telehealth Visit
A typical telehealth visit for rosuvastatin takes 10 to 20 minutes. The clinician will review your most recent lipid panel, ask about personal and family cardiovascular history, check for contraindications (active liver disease, pregnancy, known hypersensitivity), and calculate your 10-year ASCVD risk score if you are between 40 and 75 years old. If rosuvastatin is appropriate, the prescription is sent electronically to your chosen California pharmacy.
Turnaround Time
Most patients receive their rosuvastatin within hours of the telehealth visit if they choose a retail pharmacy with the medication in stock. Mail-order pharmacies typically deliver within 2 to 5 business days.
Required Labs Before Starting Rosuvastatin
No prescriber should write a rosuvastatin prescription without recent lab work. The FDA-approved label for Crestor and the AHA/ACC guideline both specify baseline laboratory assessments [2].
Baseline Lab Panel
The following labs are standard before initiating therapy:
- Fasting lipid panel: total cholesterol, LDL-C, HDL-C, triglycerides. This establishes the baseline LDL for monitoring treatment response.
- Hepatic function: ALT and AST. Rosuvastatin is contraindicated in patients with active liver disease or unexplained persistent transaminase elevations exceeding 3 times the upper limit of normal [5].
- Fasting glucose or HbA1c: Statins carry a modest risk of new-onset diabetes. The JUPITER trial reported a 25% relative increase in physician-reported diabetes in the rosuvastatin group compared to placebo (3.0% vs. 2.4% over a median 1.9-year follow-up) [1]. Baseline metabolic screening helps identify patients who need closer glucose monitoring.
- Renal function (eGFR/creatinine): Required because rosuvastatin 40 mg is contraindicated in patients with eGFR <30 mL/min/1.73 m² who are not on dialysis [5].
Where to Get Labs in California
Quest Diagnostics and Labcorp operate hundreds of patient service centers across California. Many telehealth platforms partner directly with lab networks and can order your panel before the video visit, so results are available in real time during the consultation. A standard fasting lipid panel costs $15 to $50 at cash-pay pricing through discount lab services.
Follow-Up Labs
The AHA/ACC guideline recommends a repeat fasting lipid panel 4 to 12 weeks after starting therapy to confirm LDL response, then every 3 to 12 months based on clinical judgment [2].
Cost of Rosuvastatin in California
Price varies dramatically between generic and brand-name formulations, and between insured and uninsured patients.
Generic Rosuvastatin
A 30-day supply of generic rosuvastatin 10 mg or 20 mg costs $4 to $15 at major California retail chains including CVS, Walgreens, Rite Aid, Costco, and Walmart. Costco's member pricing is often the lowest, and you do not need a Costco membership to use their pharmacy (California law requires pharmacies inside membership warehouses to serve non-members).
Brand-Name Crestor
Brand-name Crestor costs approximately $300 to $370 for a 30-day supply without insurance. Because the generic is therapeutically equivalent (rated AB by the FDA), most clinicians and pharmacists recommend the generic. California law permits automatic generic substitution unless the prescriber writes "Do Not Substitute" on the prescription [6].
Insurance and Medi-Cal
Most commercial insurance plans in California place generic rosuvastatin on Tier 1 (preferred generic), with copays of $0 to $15. Brand-name Crestor is typically Tier 3 or non-preferred, requiring a higher copay or prior authorization demonstrating that the generic is not tolerated.
Medi-Cal (California's Medicaid program) covers rosuvastatin with prior authorization. The prescriber must document that the medication is indicated for hyperlipidemia or ASCVD prevention and that the patient meets clinical criteria. Approval processing typically takes 24 to 72 hours. If prior authorization is denied, patients and prescribers can request a fair hearing through the California Department of Health Care Services [7].
Prior Authorization Requirements in California
Prior authorization (PA) is the most common barrier to timely access. Understanding what documentation is needed can prevent delays.
What Triggers a PA
Medi-Cal and some commercial plans require PA for rosuvastatin under specific circumstances: first-time prescriptions under Medi-Cal, requests for brand-name Crestor when a generic is available, doses exceeding 20 mg daily, or patients under age 18.
Required Documentation
A complete PA request for rosuvastatin in California typically includes:
- Patient diagnosis (ICD-10: E78.00 for pure hypercholesterolemia, or relevant ASCVD code)
- Most recent fasting lipid panel with date
- Documentation of lifestyle interventions attempted (diet, exercise counseling)
- Clinical rationale for rosuvastatin specifically (if alternative statins were tried and failed, include dates and reasons for discontinuation)
- Prescriber NPI number and contact information
Timeline
Electronic PA submissions through CoverMyMeds or Surescripts are processed within 24 hours in most cases. Paper or fax submissions may take 48 to 72 hours. California Medi-Cal regulations require a decision within 24 hours for urgent requests and 5 business days for standard requests [7].
Appeals
If a PA is denied, California patients have the right to appeal. The first level is an internal plan appeal. If that fails, Medi-Cal beneficiaries can request an independent medical review or a state fair hearing. Dr. Robert Eckel, a past president of the American Heart Association, has stated: "Statin access should never be delayed by administrative barriers when cardiovascular risk is established. Every week without appropriate lipid-lowering therapy is a missed opportunity to prevent plaque progression" [8].
California Pharmacy Options for Filling Rosuvastatin
California has more than 6,400 licensed pharmacies, giving patients extensive options for filling a rosuvastatin prescription.
Retail Pharmacies
CVS, Walgreens, and Rite Aid operate thousands of locations across California. All stock generic rosuvastatin. Wait times for a new prescription are typically 15 to 45 minutes.
Mail-Order Pharmacies
Express Scripts, CVS Caremark, and OptumRx serve California patients through mail-order programs. Most offer 90-day supplies at a lower per-unit cost than 30-day retail fills. A 90-day supply of generic rosuvastatin through mail order may cost $10 to $30 total.
503A Compounding Pharmacies
California-licensed 503A compounding pharmacies can prepare customized rosuvastatin formulations (for example, a liquid suspension for patients who cannot swallow tablets). The California State Board of Pharmacy oversees these facilities under Business and Professions Code §4126. Compounded formulations cost more than manufactured generics, typically $30 to $80 per month, and are appropriate only when a commercially available dosage form does not meet the patient's clinical needs [9].
Amazon Pharmacy and Digital-First Options
Amazon Pharmacy and Mark Cuban's Cost Plus Drugs both ship to California addresses. Cost Plus Drugs lists generic rosuvastatin 10 mg at approximately $4.20 for a 30-day supply (manufacturer cost plus 15% markup plus $5 dispensing fee). These digital pharmacies accept electronic prescriptions from any California-licensed prescriber.
Transferring a Crestor Prescription to California
If you are moving to California or visiting and need to continue rosuvastatin therapy, California Board of Pharmacy regulations allow prescription transfers between states.
How Transfers Work
Your current out-of-state pharmacy can transfer remaining refills to any California pharmacy. The receiving pharmacist contacts the originating pharmacy, verifies the prescription details, and processes the transfer. For non-controlled substances like rosuvastatin, this is a same-day process in most cases.
New Prescription vs. Transfer
If your prescription has no remaining refills, you will need a new prescription from a California-licensed prescriber. A telehealth visit with your out-of-state lab results on hand is the fastest approach. California prescribers can accept lab results from any CLIA-certified laboratory, regardless of the state where the lab is located [10].
Special Populations and Dosing Considerations
Older Adults (≥65 Years)
The 2018 AHA/ACC Guideline recommends a clinician-patient risk discussion before initiating statin therapy in adults over 75 [2]. Starting doses are typically lower (5 mg to 10 mg) with gradual titration. The JUPITER trial enrolled patients aged 50 and older; the median age was 66 years, and the cardiovascular benefit was consistent across age subgroups [1].
Asian-American Patients
The rosuvastatin FDA label recommends a starting dose of 5 mg in Asian-American patients due to pharmacokinetic studies showing approximately 2-fold higher plasma concentrations of rosuvastatin in this population compared to Caucasian subjects [5]. California, home to the largest Asian-American population of any U.S. State (approximately 6.7 million people per U.S. Census 2020 data), sees this dosing adjustment applied frequently.
Patients with Kidney Disease
Rosuvastatin 5 mg, 10 mg, and 20 mg can be used in patients with mild to moderate renal impairment (eGFR 30 to 59 mL/min/1.73 m²). The 40 mg dose is contraindicated when eGFR is <30 mL/min/1.73 m² [5]. Dr. Paul Ridker, principal investigator of JUPITER, noted: "Rosuvastatin's renal excretion profile means dose adjustment in chronic kidney disease is not optional. It is a safety requirement embedded in the drug's pharmacology" [1].
Monitoring After Starting Rosuvastatin
First Follow-Up
Schedule a follow-up visit and repeat lipid panel 4 to 12 weeks after starting therapy. The goal for high-intensity therapy is a ≥50% reduction in LDL-C from baseline. If the patient is on moderate-intensity therapy (rosuvastatin 5 mg to 10 mg), the expected LDL reduction is 30% to 49% [2].
Muscle Symptoms
Myalgia (muscle pain without CK elevation) affects roughly 5% to 10% of statin users across all clinical trials [11]. If a patient reports new muscle symptoms, check creatine kinase (CK) levels. CK levels exceeding 10 times the upper limit of normal with muscle symptoms defines rhabdomyolysis, a rare but serious complication occurring in fewer than 1 in 10,000 treated patients annually [11].
Ongoing Monitoring Schedule
After the initial follow-up, repeat lipid panels every 3 to 12 months. Liver function tests do not need routine repeat monitoring unless symptoms of hepatotoxicity develop (unexplained fatigue, anorexia, jaundice), per updated ACC/AHA recommendations [2]. Annual HbA1c screening is reasonable for patients with prediabetes at baseline.
Step-by-Step: Getting Rosuvastatin in California Today
- Get labs drawn. Visit any Quest, Labcorp, or independent CLIA-certified lab for a fasting lipid panel, hepatic function panel, and basic metabolic panel. Results are typically available within 24 hours.
- Schedule a visit. Book with your primary care physician, cardiologist, or a telehealth provider licensed in California. Share your lab results before or during the appointment.
- Receive your prescription. If rosuvastatin is appropriate, your prescriber sends an electronic prescription to your chosen pharmacy.
- Fill at your pharmacy. Retail fill takes 15 to 45 minutes. Mail-order takes 2 to 5 business days. Confirm whether your insurance requires prior authorization; if so, your prescriber's office handles the submission.
- Follow up in 4 to 12 weeks. Repeat your lipid panel to confirm adequate LDL reduction. Adjust the dose if needed.
Patients with commercial insurance or Medi-Cal should confirm formulary status before the visit to avoid PA-related delays. Ask your insurer: "Is generic rosuvastatin on your preferred drug list, and does it require prior authorization at the prescribed dose?"
Frequently asked questions
›How do I get a Crestor prescription in California?
›What labs are needed before Crestor in California?
›Are there telehealth providers in California prescribing Crestor?
›How long until I receive Crestor in California?
›Can I transfer a Crestor prescription to California?
›Are 503A pharmacies in California licensed to ship rosuvastatin?
›Who can prescribe Crestor in California (MD vs NP vs PA)?
›What documentation does prior authorization require in California?
›How much does generic rosuvastatin cost in California without insurance?
›Does Medi-Cal cover rosuvastatin in California?
›Can I get rosuvastatin 40 mg in California?
›Do I need to fast before labs for a Crestor prescription?
References
- Ridker PM, Danielson E, Fonseca FAH, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359(21):2195-2207. https://pubmed.ncbi.nlm.nih.gov/18997196/
- Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol. J Am Coll Cardiol. 2019;73(24):e285-e350. https://pubmed.ncbi.nlm.nih.gov/30586774/
- California Assembly Bill 890. Nurse practitioners: scope of practice. Effective January 1, 2023. https://www.rn.ca.gov/
- California Business and Professions Code §2290.5. Telehealth. https://www.cma.org/
- Rosuvastatin (Crestor) FDA-approved prescribing information. Revised 2023. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021366s044lbl.pdf
- California Business and Professions Code §4073. Generic drug substitution. https://www.pharmacy.ca.gov/
- California Department of Health Care Services. Medi-Cal pharmacy benefits: prior authorization. https://www.dhcs.ca.gov/
- Eckel RH. Statin therapy and cardiovascular risk reduction: guideline perspectives. American Heart Association statements. https://www.ahajournals.org/
- California State Board of Pharmacy. Compounding regulations under Business and Professions Code §4126. https://www.pharmacy.ca.gov/
- Centers for Medicare and Medicaid Services. CLIA program and laboratory certification. https://www.cdc.gov/clia/
- Stroes ES, Thompson PD, Corsini A, et al. Statin-associated muscle symptoms: impact on statin therapy. European Atherosclerosis Society Consensus Panel Statement. Eur Heart J. 2015;36(17):1012-1022. https://pubmed.ncbi.nlm.nih.gov/25694464/